| 注册
首页|期刊导航|实用医学杂志|慢性髓系白血病SOX17基因表达及甲基化的临床研究

慢性髓系白血病SOX17基因表达及甲基化的临床研究

唐春艳 肖高飞 杨磊 钱军 安翠 姚冬明 刘清 郭竑 闻向梅 林江 马吉春 张铭

实用医学杂志Issue(19):3070-3072,3.
实用医学杂志Issue(19):3070-3072,3.DOI:10.3969/j.issn.1006-5725.2014.19.012

慢性髓系白血病SOX17基因表达及甲基化的临床研究

Clinical study on expression and methylation of SOX17 gene in chronic myeloid leukemia

唐春艳 1肖高飞 2杨磊 1钱军 1安翠 1姚冬明 2刘清 1郭竑 2闻向梅 2林江 2马吉春 2张铭1

作者信息

  • 1. 212002 江苏省镇江市,江苏大学附属人民医院血液科
  • 2. 212002 江苏省镇江市,江苏大学附属人民医院中心实验室
  • 折叠

摘要

Abstract

Objective To investigate the expression level and promoter methylation of SOX17 gene and the clinical correlations in Chinese patients with chronic myeloid leukemia ( CML ) . Methods The levels of SOX17 expression and methylation were detected by RQ-PCR and RQ-MSP. Results SOX17 expression level was significantly lower in CML compared with 30 controls (P=0.001). The area under the receiver operating characteristic (ROC) curve (AUC) was 0.748 to differentiate CML from control (P=0.001). There was a trend of correlation between SOX17 expression and bcr/abl transcript (r = 0.439,P = 0.068) in CML patients. Hypermethylation of SOX17 promoter was detected in 3 (4%) CML patients, however, there was no difference as compared with 32 controls. In our study, SOX17 hypermethylation was not corrected with its expression. Conclusion Decreased SOX17 expression is a common molecular event in CML and may be considered as an available biomarker to diagnose CML. Dysregulated SOX17 is not caused by promoter hypermethylation in CML.

关键词

慢性髓系白血病/SOX17/低表达/甲基化

Key words

Chronic myeloid leukemia/SOX17/Low expression/Hypermethylation

引用本文复制引用

唐春艳,肖高飞,杨磊,钱军,安翠,姚冬明,刘清,郭竑,闻向梅,林江,马吉春,张铭..慢性髓系白血病SOX17基因表达及甲基化的临床研究[J].实用医学杂志,2014,(19):3070-3072,3.

基金项目

国家自然科学基金资助项目(编号81270630,81172592);江苏省科技厅临床医学科技专项课题(编号BL2012056);江苏省“333工程”项目(编号BRA2011085, BRA2013136);镇江市医学重点人才、镇江市社会发展项目(编号SH2013042,SH2013082);江苏大学临床医学科技发展基金资助项目 ()

实用医学杂志

OA北大核心CSTPCD

1006-5725

访问量0
|
下载量0
段落导航相关论文